Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Genetic Biopsy for Prediction of Surveillance Intervals after Endoscopic Resection of Colonic Polyps: Results of the GENESIS Study.

Berger AW, Raedler K, Langner C, Ludwig L, Dikopoulos N, Becker KF, Slotta-Huspenina J, Quante M, Schwerdel D, Perkhofer L, Kleger A, Zizer E, Oswald F, Seufferlein T, Meining A.

United European Gastroenterol J. 2018 Mar;6(2):290-299. doi: 10.1177/2050640617723810. Epub 2017 Jul 28.

2.

Gut microbiota modulate T cell trafficking into human colorectal cancer.

Cremonesi E, Governa V, Garzon JFG, Mele V, Amicarella F, Muraro MG, Trella E, Galati-Fournier V, Oertli D, Däster SR, Droeser RA, Weixler B, Bolli M, Rosso R, Nitsche U, Khanna N, Egli A, Keck S, Slotta-Huspenina J, Terracciano LM, Zajac P, Spagnoli GC, Eppenberger-Castori S, Janssen KP, Borsig L, Iezzi G.

Gut. 2018 Feb 6. pii: gutjnl-2016-313498. doi: 10.1136/gutjnl-2016-313498. [Epub ahead of print]

PMID:
29437871
3.

[Large thoracic tumor : Easy diagnosis - isn't it?]

Sträter A, Huber A, Slotta-Huspenina J, Rummeny E, Holzapfel K.

Radiologe. 2018 Feb;58(2):148-152. doi: 10.1007/s00117-017-0345-5. German. No abstract available.

PMID:
29305622
4.

Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics.

Habringer S, Lapa C, Herhaus P, Schottelius M, Istvanffy R, Steiger K, Slotta-Huspenina J, Schirbel A, Hänscheid H, Kircher S, Buck AK, Götze K, Vick B, Jeremias I, Schwaiger M, Peschel C, Oostendorp R, Wester HJ, Grigoleit GU, Keller U.

Theranostics. 2018 Jan 1;8(2):369-383. doi: 10.7150/thno.21397. eCollection 2018.

5.

Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus.

Münch S, Pigorsch SU, Feith M, Slotta-Huspenina J, Weichert W, Friess H, Combs SE, Habermehl D.

Radiat Oncol. 2017 Nov 21;12(1):182. doi: 10.1186/s13014-017-0904-y.

6.

Pharmacoproteomic characterisation of human colon and rectal cancer.

Frejno M, Zenezini Chiozzi R, Wilhelm M, Koch H, Zheng R, Klaeger S, Ruprecht B, Meng C, Kramer K, Jarzab A, Heinzlmeir S, Johnstone E, Domingo E, Kerr D, Jesinghaus M, Slotta-Huspenina J, Weichert W, Knapp S, Feller SM, Kuster B.

Mol Syst Biol. 2017 Nov 3;13(11):951. doi: 10.15252/msb.20177701.

7.

A novel pretherapeutic gene expression-based risk score for treatment guidance in gastric cancer.

Bauer L, Hapfelmeier A, Blank S, Reiche M, Slotta-Huspenina J, Jesinghaus M, Novotny A, Schmidt T, Grosser B, Kohlruss M, Weichert W, Ott K, Keller G.

Ann Oncol. 2018 Jan 1;29(1):127-132. doi: 10.1093/annonc/mdx685.

PMID:
29069277
8.

Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer.

Niklaus M, Adams O, Berezowska S, Zlobec I, Graber F, Slotta-Huspenina J, Nitsche U, Rosenberg R, Tschan MP, Langer R.

Oncotarget. 2017 May 2;8(33):54604-54615. doi: 10.18632/oncotarget.17554. eCollection 2017 Aug 15.

9.

A20 deletion in T cells modulates acute graft-versus-host disease in mice.

Fischer JC, Otten V, Steiger K, Schmickl M, Slotta-Huspenina J, Beyaert R, van Loo G, Peschel C, Poeck H, Haas T, Spoerl S.

Eur J Immunol. 2017 Nov;47(11):1982-1988. doi: 10.1002/eji.201646911. Epub 2017 Sep 15.

PMID:
28833031
10.

Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.

Jesinghaus M, Steiger K, Slotta-Huspenina J, Drecoll E, Pfarr N, Meyer P, Konukiewitz B, Bettstetter M, Wieczorek K, Ott K, Feith M, Langer R, Weichert W, Specht K, Boxberg M.

Oncotarget. 2017 Jul 18;8(29):46756-46768. doi: 10.18632/oncotarget.18606.

11.

Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities.

Herhaus P, Habringer S, Vag T, Steiger K, Slotta-Huspenina J, Gerngroß C, Wiestler B, Wester HJ, Schwaiger M, Keller U.

EJNMMI Res. 2017 Dec;7(1):51. doi: 10.1186/s13550-017-0294-z. Epub 2017 Jun 2.

12.

A Novel Grading System Based on Tumor Budding and Cell Nest Size Is a Strong Predictor of Patient Outcome in Esophageal Squamous Cell Carcinoma.

Jesinghaus M, Boxberg M, Konukiewitz B, Slotta-Huspenina J, Schlitter AM, Steiger K, Specht K, Wieczorek K, Warth A, Schmidt T, Hartmann A, Demir IE, Feith M, Ott K, Weichert W.

Am J Surg Pathol. 2017 Aug;41(8):1112-1120. doi: 10.1097/PAS.0000000000000865.

PMID:
28505009
13.

Expression patterns of programmed death-ligand 1 in esophageal adenocarcinomas: comparison between primary tumors and metastases.

Dislich B, Stein A, Seiler CA, Kröll D, Berezowska S, Zlobec I, Galvan J, Slotta-Huspenina J, Walch A, Langer R.

Cancer Immunol Immunother. 2017 Jun;66(6):777-786. doi: 10.1007/s00262-017-1982-2. Epub 2017 Mar 13.

PMID:
28289861
14.

Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.

Schmiegel W, Scott RJ, Dooley S, Lewis W, Meldrum CJ, Pockney P, Draganic B, Smith S, Hewitt C, Philimore H, Lucas A, Shi E, Namdarian K, Chan T, Acosta D, Ping-Chang S, Tannapfel A, Reinacher-Schick A, Uhl W, Teschendorf C, Wolters H, Stern J, Viebahn R, Friess H, Janssen KP, Nitsche U, Slotta-Huspenina J, Pohl M, Vangala D, Baraniskin A, Dockhorn-Dworniczak B, Hegewisch-Becker S, Ronga P, Edelstein DL, Jones FS, Hahn S, Fox SB.

Mol Oncol. 2017 Feb;11(2):208-219. doi: 10.1002/1878-0261.12023. Epub 2017 Jan 20.

15.

Federated Biobanking with Corporate Service Unit: The Munich Biobank Alliance Blueprint.

Thasler RM, Berghammer AJ, Kirchner T, Slotta-Huspenina J, Becker KF, Schiergens T, Thasler WE, Wichmann HE.

Biopreserv Biobank. 2017 Feb;15(1):75-79. doi: 10.1089/bio.2016.0101. Epub 2016 Dec 19. No abstract available.

PMID:
27991833
16.

Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry.

Bassani-Sternberg M, Bräunlein E, Klar R, Engleitner T, Sinitcyn P, Audehm S, Straub M, Weber J, Slotta-Huspenina J, Specht K, Martignoni ME, Werner A, Hein R, H Busch D, Peschel C, Rad R, Cox J, Mann M, Krackhardt AM.

Nat Commun. 2016 Nov 21;7:13404. doi: 10.1038/ncomms13404.

17.

RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells.

Höckendorf U, Yabal M, Herold T, Munkhbaatar E, Rott S, Jilg S, Kauschinger J, Magnani G, Reisinger F, Heuser M, Kreipe H, Sotlar K, Engleitner T, Rad R, Weichert W, Peschel C, Ruland J, Heikenwalder M, Spiekermann K, Slotta-Huspenina J, Groß O, Jost PJ.

Cancer Cell. 2016 Jul 11;30(1):75-91. doi: 10.1016/j.ccell.2016.06.002.

18.

Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia.

Herhaus P, Habringer S, Philipp-Abbrederis K, Vag T, Gerngross C, Schottelius M, Slotta-Huspenina J, Steiger K, Altmann T, Weißer T, Steidle S, Schick M, Jacobs L, Slawska J, Müller-Thomas C, Verbeek M, Subklewe M, Peschel C, Wester HJ, Schwaiger M, Götze K, Keller U.

Haematologica. 2016 Aug;101(8):932-40. doi: 10.3324/haematol.2016.142976. Epub 2016 May 12.

19.

A new model of implant-related osteomyelitis in the metaphysis of rat tibiae.

Harrasser N, Gorkotte J, Obermeier A, Feihl S, Straub M, Slotta-Huspenina J, von Eisenhart-Rothe R, Moser W, Gruner P, de Wild M, Gollwitzer H, Burgkart R.

BMC Musculoskelet Disord. 2016 Apr 8;17:152. doi: 10.1186/s12891-016-1005-z.

20.

Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.

Thies S, Guldener L, Slotta-Huspenina J, Zlobec I, Koelzer VH, Lugli A, Kröll D, Seiler CA, Feith M, Langer R.

Hum Pathol. 2016 Jun;52:1-8. doi: 10.1016/j.humpath.2016.01.016. Epub 2016 Feb 10.

PMID:
26980046
21.

High-resolution manometry in patients with eosinophilic esophagitis under topical steroid therapy-a prospective observational study (HIMEOS-study).

Nennstiel S, Bajbouj M, Becker V, Slotta-Huspenina J, Wagenpfeil S, Schmid RM, Schlag C.

Neurogastroenterol Motil. 2016 Apr;28(4):599-607. doi: 10.1111/nmo.12753. Epub 2016 Feb 17.

PMID:
26891170
22.

Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit.

Geyer PE, Maak M, Nitsche U, Perl M, Novotny A, Slotta-Huspenina J, Dransart E, Holtorf A, Johannes L, Janssen KP.

Mol Cancer Ther. 2016 May;15(5):1008-17. doi: 10.1158/1535-7163.MCT-15-0633. Epub 2016 Jan 29.

23.

Neural influences on human intestinal epithelium in vitro.

Krueger D, Michel K, Zeller F, Demir IE, Ceyhan GO, Slotta-Huspenina J, Schemann M.

J Physiol. 2016 Jan 15;594(2):357-72. doi: 10.1113/JP271493. Epub 2015 Nov 23.

24.

Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational study.

Schmid SC, Thümer L, Schuster T, Horn T, Kurtz F, Slotta-Huspenina J, Seebach J, Straub M, Maurer T, Autenrieth M, Kübler H, Retz M, Protzer U, Gschwend JE, Hoffmann D.

Infect Agent Cancer. 2015 Sep 21;10:31. doi: 10.1186/s13027-015-0028-7. eCollection 2015.

25.

The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.

Horn T, Laus J, Seitz AK, Maurer T, Schmid SC, Wolf P, Haller B, Winkler M, Retz M, Nawroth R, Gschwend JE, Kübler HR, Slotta-Huspenina J.

World J Urol. 2016 Feb;34(2):181-7. doi: 10.1007/s00345-015-1615-3. Epub 2015 Jun 9.

PMID:
26055646
26.

Clinical Significance of NOTCH1 and NOTCH2 Expression in Gastric Carcinomas: An Immunohistochemical Study.

Bauer L, Takacs A, Slotta-Huspenina J, Langer R, Becker K, Novotny A, Ott K, Walch A, Hapfelmeier A, Keller G.

Front Oncol. 2015 Apr 22;5:94. doi: 10.3389/fonc.2015.00094. eCollection 2015.

27.

Corrigendum. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

Rokavec M, Öner MG, Li H, Jackstadt R, Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, Slotta-Huspenina J, Bader FG, Greten FR, Hermeking H.

J Clin Invest. 2015 Mar 2;125(3):1362. doi: 10.1172/JCI81340. Epub 2015 Mar 2. No abstract available.

28.

Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients.

Knopf A, Lempart J, Bas M, Slotta-Huspenina J, Mansour N, Fritsche MK.

Oncotarget. 2015 Feb 20;6(5):3443-51.

29.

Spatial organization of the tenascin-C microenvironment in experimental and human cancer.

Spenlé C, Gasser I, Saupe F, Janssen KP, Arnold C, Klein A, van der Heyden M, Mutterer J, Neuville-Méchine A, Chenard MP, Guenot D, Esposito I, Slotta-Huspenina J, Ambartsumian N, Simon-Assmann P, Orend G.

Cell Adh Migr. 2015;9(1-2):4-13. doi: 10.1080/19336918.2015.1005452.

30.

OVSCORE - a validated score to identify ovarian cancer patients not suitable for primary surgery.

Dorn J, Bronger H, Kates R, Slotta-Huspenina J, Schmalfeldt B, Kiechle M, Diamandis EP, Soosaipillai A, Schmitt M, Harbeck N.

Oncol Lett. 2015 Jan;9(1):418-424. Epub 2014 Oct 24.

31.

Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches.

Karamitopoulou E, Thies S, Zlobec I, Ott K, Feith M, Slotta-Huspenina J, Lordick F, Becker K, Langer R.

Am J Surg Pathol. 2014 Nov;38(11):1551-6. doi: 10.1097/PAS.0000000000000255.

32.

Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial.

Gündisch S, Slotta-Huspenina J, Verderio P, Ciniselli CM, Pizzamiglio S, Schott C, Drecoll E, Viertler C, Zatloukal K, Kap M, Riegman P, Esposito I, Specht K, Babaryka G, Asslaber M, Bodó K, den Bakker M, den Hollander J, Fend F, Neumann J, Reu S, Perren A, Langer R, Lugli A, Becker I, Richter T, Kayser G, May AM, Carneiro F, Lopes JM, Sobin L, Höfler H, Becker KF.

Virchows Arch. 2014 Nov;465(5):509-19. doi: 10.1007/s00428-014-1624-4. Epub 2014 Aug 2.

PMID:
25085759
33.

Computerized analysis of enhancement kinetics for preoperative lymph node staging in rectal cancer using dynamic contrast-enhanced magnetic resonance imaging.

Vag T, Slotta-Huspenina J, Rosenberg R, Bader FG, Nitsche U, Drecoll E, Rummeny EJ, Gaa J.

Clin Imaging. 2014 Nov-Dec;38(6):845-9. doi: 10.1016/j.clinimag.2014.06.011. Epub 2014 Jun 19.

PMID:
25082173
34.

Heat Shock Protein 90 (HSP90) and Her2 in Adenocarcinomas of the Esophagus.

Slotta-Huspenina J, Becker KF, Feith M, Walch A, Langer R.

Cancers (Basel). 2014 Jun 27;6(3):1382-93. doi: 10.3390/cancers6031382.

35.

Mass-spectrometry-based draft of the human proteome.

Wilhelm M, Schlegl J, Hahne H, Gholami AM, Lieberenz M, Savitski MM, Ziegler E, Butzmann L, Gessulat S, Marx H, Mathieson T, Lemeer S, Schnatbaum K, Reimer U, Wenschuh H, Mollenhauer M, Slotta-Huspenina J, Boese JH, Bantscheff M, Gerstmair A, Faerber F, Kuster B.

Nature. 2014 May 29;509(7502):582-7. doi: 10.1038/nature13319.

PMID:
24870543
36.

Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells.

Klar R, Schober S, Rami M, Mall S, Merl J, Hauck SM, Ueffing M, Admon A, Slotta-Huspenina J, Schwaiger M, Stevanović S, Oostendorp RA, Busch DH, Peschel C, Krackhardt AM.

Leukemia. 2014 Dec;28(12):2355-66. doi: 10.1038/leu.2014.131. Epub 2014 Apr 16.

PMID:
24736212
37.

Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma.

Drecoll E, Nitsche U, Bauer K, Berezowska S, Slotta-Huspenina J, Rosenberg R, Langer R.

Int J Colorectal Dis. 2014 Jun;29(6):663-71. doi: 10.1007/s00384-014-1857-3. Epub 2014 Apr 15.

PMID:
24733427
38.

IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

Rokavec M, Öner MG, Li H, Jackstadt R, Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, Slotta-Huspenina J, Bader FG, Greten FR, Hermeking H.

J Clin Invest. 2014 Apr;124(4):1853-67. doi: 10.1172/JCI73531. Epub 2014 Mar 18. Erratum in: J Clin Invest. 2015 Mar 2;125(3):1362.

39.

Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer.

Malinowsky K, Nitsche U, Janssen KP, Bader FG, Späth C, Drecoll E, Keller G, Höfler H, Slotta-Huspenina J, Becker KF.

Br J Cancer. 2014 Apr 15;110(8):2081-9. doi: 10.1038/bjc.2014.100. Epub 2014 Mar 11.

40.

A matched-pair comparison of two different locking plates for valgus-producing medial open-wedge high tibial osteotomy: peek-carbon composite plate versus titanium plate.

Cotic M, Vogt S, Hinterwimmer S, Feucht MJ, Slotta-Huspenina J, Schuster T, Imhoff AB.

Knee Surg Sports Traumatol Arthrosc. 2015 Jul;23(7):2032-40. doi: 10.1007/s00167-014-2914-8. Epub 2014 Feb 22.

PMID:
24562634
41.

A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy.

Langer R, Becker K, Zlobec I, Gertler R, Sisic L, Büchler M, Lordick F, Slotta-Huspenina J, Weichert W, Höfler H, Feith M, Ott K.

Ann Surg Oncol. 2014 Mar;21(3):915-21. doi: 10.1245/s10434-013-3410-y. Epub 2013 Nov 27.

PMID:
24281419
42.

Tenascin-C downregulates wnt inhibitor dickkopf-1, promoting tumorigenesis in a neuroendocrine tumor model.

Saupe F, Schwenzer A, Jia Y, Gasser I, Spenlé C, Langlois B, Kammerer M, Lefebvre O, Hlushchuk R, Rupp T, Marko M, van der Heyden M, Cremel G, Arnold C, Klein A, Simon-Assmann P, Djonov V, Neuville-Méchine A, Esposito I, Slotta-Huspenina J, Janssen KP, de Wever O, Christofori G, Hussenet T, Orend G.

Cell Rep. 2013 Oct 31;5(2):482-92. doi: 10.1016/j.celrep.2013.09.014. Epub 2013 Oct 17.

43.

Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis.

Nitsche U, Zimmermann A, Späth C, Müller T, Maak M, Schuster T, Slotta-Huspenina J, Käser SA, Michalski CW, Janssen KP, Friess H, Rosenberg R, Bader FG.

Ann Surg. 2013 Nov;258(5):775-82; discussion 782-3. doi: 10.1097/SLA.0b013e3182a69f7e.

44.

Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.

Berezowska S, Novotny A, Bauer K, Feuchtinger A, Slotta-Huspenina J, Becker K, Langer R, Walch A.

PLoS One. 2013 Jul 11;8(7):e69098. doi: 10.1371/journal.pone.0069098. Print 2013.

45.

A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas.

Slotta-Huspenina J, Wolff C, Drecoll E, Feith M, Bettstetter M, Malinowsky K, Bauer L, Becker K, Ott K, Höfler H, Becker KF, Langer R.

Br J Cancer. 2013 Jul 23;109(2):370-8. doi: 10.1038/bjc.2013.319. Epub 2013 Jul 9.

46.

Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors.

Schwitalla S, Ziegler PK, Horst D, Becker V, Kerle I, Begus-Nahrmann Y, Lechel A, Rudolph KL, Langer R, Slotta-Huspenina J, Bader FG, Prazeres da Costa O, Neurath MF, Meining A, Kirchner T, Greten FR.

Cancer Cell. 2013 Jan 14;23(1):93-106. doi: 10.1016/j.ccr.2012.11.014. Epub 2012 Dec 27.

47.

SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma.

Fernández-Sáiz V, Targosz BS, Lemeer S, Eichner R, Langer C, Bullinger L, Reiter C, Slotta-Huspenina J, Schroeder S, Knorn AM, Kurutz J, Peschel C, Pagano M, Kuster B, Bassermann F.

Nat Cell Biol. 2013 Jan;15(1):72-81.

PMID:
23263282
48.

Epidermal growth factor receptor, phosphatidylinositol-3-kinase catalytic subunit/PTEN, and KRAS/NRAS/BRAF in primary resected esophageal adenocarcinomas: loss of PTEN is associated with worse clinical outcome.

Bettstetter M, Berezowska S, Keller G, Walch A, Feuchtinger A, Slotta-Huspenina J, Feith M, Drecoll E, Höfler H, Langer R.

Hum Pathol. 2013 May;44(5):829-36. doi: 10.1016/j.humpath.2012.08.005. Epub 2012 Nov 14.

PMID:
23158210
49.

Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.

Nitsche U, Rosenberg R, Balmert A, Schuster T, Slotta-Huspenina J, Herrmann P, Bader FG, Friess H, Schlag PM, Stein U, Janssen KP.

Ann Surg. 2012 Nov;256(5):763-71; discussion 771. doi: 10.1097/SLA.0b013e318272de87.

PMID:
23095620
50.

Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas.

Slotta-Huspenina J, Berg D, Bauer K, Wolff C, Malinowsky K, Bauer L, Drecoll E, Bettstetter M, Feith M, Walch A, Höfler H, Becker KF, Langer R.

PLoS One. 2012;7(7):e41420. doi: 10.1371/journal.pone.0041420. Epub 2012 Jul 24.

Supplemental Content

Loading ...
Support Center